Michael J. LaBarre - Oct 1, 2021 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, Chief Technical Officer
Signature
/s/ James R. Oehler as attorney-in-fact for Michael J. LaBarre
Stock symbol
HALO
Transactions as of
Oct 1, 2021
Transactions value $
-$790,173
Form type
4
Date filed
10/1/2021, 07:32 PM
Previous filing
Jul 15, 2021
Next filing
Oct 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $386K +29.5K +19.79% $13.10 178K Oct 1, 2021 Direct F1
transaction HALO Common Stock Sale -$1.18M -29.5K -16.52% $39.93 149K Oct 1, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Option to Purchase Common Stock Options Exercise $0 -29.5K -78.53% $0.00 8.05K Oct 1, 2021 Common Stock 29.5K $13.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents a weighted average sales price per share. These shares were sold at prices ranging from $39.528 to $40.50. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
F3 This option was granted on February 6, 2014 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter.